Skip to content
Nonprofiteer
← ALLIANCE FOR CANCER GENE THERAPY INC

Form 990 for tax year 2025

Filed by ALLIANCE FOR CANCER GENE THERAPY INC.

Totals

Total revenue
$5,167,910
Total expenses
$3,128,633
Contributions and grants received
$3,511,245
Grants paid
$2,036,801
Program service revenue
$134,973
Investment income
$1,340,486
Other revenue
$181,206
Total assets, end of year
$20,157,168
Total liabilities, end of year
$3,503,835
Net assets or fund balances, end of year
$16,653,333
Program services expenses (Part IX)
$2,673,605
Management and general expenses
$53,874
Fundraising expenses
$401,154
Program service expenses (Part III)
$2,673,605

Program services were 85.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1f · All other contributions, gifts and grants

    $3,511,245

  • 2a · Program service revenue: ACGT SUMMIT 2026

    total $134,973 · related or exempt $134,973

  • 3 · Investment income

    total $460,356 · excluded $460,356

  • 5 · Royalties

    total $181,206 · related or exempt $181,206

  • 7a · Gross sales of assets other than inventory

    securities $9,746,636

  • 7b · Less cost or other basis and sales expenses

    securities $8,866,506

  • 7c · Gain or loss

    securities $880,130

  • 7d · Net gain or loss

    total $880,130 · excluded $880,130

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $2,036,801 · program services $2,036,801

  • 5 · Compensation of officers, directors and key employees

    total $511,525 · program services $281,339 · fundraising $230,186

  • 7 · Other salaries and wages

    total $65,757 · program services $36,167 · fundraising $29,590

  • 9 · Other employee benefits

    total $18,852 · program services $10,368 · fundraising $8,484

  • 10 · Payroll taxes

    total $34,949 · program services $19,222 · fundraising $15,727

  • 11b · Fees: legal

    total $861 · program services $646 · management and general $215

  • 11g · Fees: other

    total $104,434 · program services $53,957 · management and general $25,726 · fundraising $24,751

  • 12 · Advertising and promotion

    total $38,278 · program services $9,814 · fundraising $28,464

  • 13 · Office expenses

    total $21,676 · program services $10,838 · fundraising $10,838

  • 14 · Information technology

    total $75,552 · program services $39,050 · management and general $18,035 · fundraising $18,467

  • 17 · Travel

    total $37,045 · program services $25,454 · fundraising $11,591

  • 19 · Conferences, conventions and meetings

    total $159,735 · program services $139,863 · management and general $1,060 · fundraising $18,812

  • 24a · Other expenses: MISCELLANEOUS

    total $23,168 · program services $10,086 · management and general $8,838 · fundraising $4,244

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $454,545 · end of year $1,289,507

  • 2 · Savings and temporary cash investments

    beginning of year $2,819,391 · end of year $5,001,776

  • 3 · Pledges and grants receivable

    beginning of year $162,208 · end of year $170,851

  • 9 · Prepaid expenses and deferred charges

    beginning of year $98,517 · end of year $34,497

  • 11 · Investments: publicly traded securities

    beginning of year $12,198,367 · end of year $13,660,537

  • 17 · Accounts payable and accrued expenses

    beginning of year $32,587 · end of year $27,714

  • 18 · Grants payable

    beginning of year $3,474,304 · end of year $3,476,121

  • 27 · Net assets without donor restrictions

    beginning of year $12,226,137 · end of year $16,653,333

Mission and programs · 2025

Mission

ACGT SUPPORTS HIGH-RISK, HIGH-REWARD SCIENTIFIC RESEARCH TO DEVELOP CANCER THERAPEUTICS THAT USE THE BODY'S OWN CELLS AND GENES AS A LIVING MEDICINE. BY ACCELERATING THIS RESEARCH, ACGT IS HELPING TO ADVANCE THERAPIES THAT ARE SIGNIFICANTLY MORE EFFECTIVE AND LESS TOXIC THAN CURRENT CANCER TREATMENTS SUCH AS CHEMOTHERAPY AND RADIATION.

Activities or mission (Part I)

ALLIANCE FOR CANCER GENE THERAPY (ACGT) FUNDS THE MOST INNOVATIVE SCIENTISTS (CONTINUED IN SCH O) WORKING TO HARNESS THE POWER OF CELL AND GENE THERAPY TO TRANSFORM HOW CANCER IS TREATED AND DRIVE MOMENTUM TOWARD A CURE.

  • Withheld by Nonprofiteer: this text may name a private individual.

    Expenses $2,673,605 · Grants $2,036,801 · Revenue $316,179

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here. A text marked withheld matched a screen for wording that may name a private individual, such as an honorific or "in memory of". Most of what it withholds names no one; it is withheld so that what does is never shown.

Listed in Part VII

  • Kevin Honeycutt

    CEO & PRESIDENT

    Total calculated
    $0
    Hours/week
    40

  • Jonathan Doctor

    DIRECTOR (EFF 3/12/26)

    Total calculated
    $0
    Hours/week
    1

  • Marc Engelsgjerd MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Daniel Englander

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Maria Fardis PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Peter A Glicklich Esq

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Michael Gregory

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Chau Q Khuong

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • John Lahey PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Alexandra Landes

    DIRECTOR (THRU 6/20/25)

    Total calculated
    $0
    Hours/week
    1

  • Bruce L Levine PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • John Neamonitis

    DIRECTOR (EFF 3/12/26)

    Total calculated
    $0
    Hours/week
    1

  • Barbara Netter

    DIRECTOR, HONORARY CHAIRMAN

    Total calculated
    $0
    Hours/week
    6

  • Chen Schor

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • John C Sites Jr

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Klaus R Veitinger MD PhD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • Martin E Winter

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • H William Smith

    VICE PRESIDENT, LEGAL & SECRETARY

    Total calculated
    $0
    Hours/week
    2

  • Colleen Maggi

    VICE PRESIDENT, TREAS (EFF 6/25)

    Total calculated
    $0
    Hours/week
    2

  • Christine Herman

    VICE PRESIDENT, TREAS (THRU 5/25)

    Total calculated
    $0
    Hours/week
    2

  • Barbara Lavery

    CHIEF PROGRAM OFFICER

    Total calculated
    $293,636
    From this org
    $271,039
    From related orgs
    $0
    Other
    $22,597
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $233,717
    Bonus
    $35,000
    Other
    $2,322
    Deferred
    $6,242
    Nontaxable benefits
    $16,355
    Filer's total
    $293,636

  • Keri Eisenberg

    CHIEF PHILANTHROPY OFFICER

    Total calculated
    $229,111
    From this org
    $220,863
    From related orgs
    $0
    Other
    $8,248
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $190,962
    Bonus
    $15,000
    Other
    $14,901
    Deferred
    $6,626
    Nontaxable benefits
    $1,622
    Filer's total
    $229,111

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

None.

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Provenance

Return type
form_990
Tax year
2025
Filed
14 September 2026
IRS schema version
2025v4.2
Source object
202642589349300834

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.